1800 202 8726
Lenvatinib side effects

Hand-Foot Skin Reaction — on Lenvatinib: Prevention and Relief

Hand-foot skin reaction is one of the most common side effects of lenvatinib. It is not usually dangerous at first, but it can move from redness to painful blistering within days if the skin is not protected early.

Medically reviewed by Dr. Bharati Devi Gorantla, Medical Oncologist, MBBS · MD · DM (Adyar, Chennai) · ECMO · MRCP SCE (UK) · Last reviewed August 2026

  • Not dangerous at first — Mild redness and sensitivity are uncomfortable but manageable. Most people continue treatment with good skin care.
  • Prevention beats treatment — Starting a thick moisturiser routine before symptoms appear is more effective than treating blisters after they form.
  • Blistering changes the picture — Open skin or blisters that stop you walking need same-day contact with your team, not a wait-and-see approach.
  • Your dose may need adjusting — Moderate to severe reactions often require a temporary dose pause. This is expected and does not mean the treatment has failed.
4.8 · 800+ Google reviews · 15,000+ patients treated
Limited Slots Today

Talk to a medical oncologist

₹950   Today: FREE  ·  Including free written second opinion

Reply within 2 working hours
Reviewed by a senior medical oncologist
Confidential. No commitment to start treatment.
or
Call 1800 202 8726
17+
Cancer Specialists
on Panel
96.9%
Breast Cancer
Survival Rate*
15,000+
Patients
Treated
4.8★
Google Rating
(800+ reviews)

Hand-foot skin reaction on lenvatinib is uncomfortable but not usually dangerous. It becomes urgent when blistering, open sores, or pain that stops you walking appears. NCCN guidance on targeted therapy side effects recommends same-day contact at that point. Before it reaches that stage, a daily moisturising routine is the most effective way to stay ahead of it.

What can you do to prevent and manage the reaction at home?

  • Start moisturising before symptoms appearUse a thick, urea-based cream or petroleum jelly on hands and feet from your first week on lenvatinib.
  • Apply cream at least twice a dayMorning and night — more often if skin feels dry. Apply generously, not a thin layer.
  • Wear cotton gloves or socks overnightApply cream, then cover with cotton so it absorbs while you sleep and reduces friction.
  • Use warm water, not hotHot water strips the skin's protective oils. Use warm or cool water when bathing or washing hands.
  • Choose padded, well-fitting shoesPressure from tight or hard-soled shoes worsens the reaction at the soles. Padded insoles reduce it.
  • Tell your team about thickened skin earlyThickened patches can be treated before they crack. Do not cut or shave calluses yourself.

How serious is your reaction right now?

FeatureMild — manage at homeModerate — call your team todaySevere — urgent review needed
Skin appearanceRedness, warmth, or sensitivity over pressure areasBlisters, painful cracks, or peeling skinOpen sores, weeping skin, or signs of infection
Pain levelMinimal — does not change what you doUncomfortable — some daily tasks affectedStops you walking or using your hands
Effect on daily lifeNoneSome activities harder than usualSelf-care significantly limited
Typically startsMost often in the first few weeks of treatment — but can appear at any point
What to doContinue skin care routineCall your oncology team the same dayContact your team urgently or go to hospital

Not sure what this means for you?

Share your reports and a senior oncologist will explain your options in plain language — no obligation to start treatment.

Meet the Specialists

17+ senior cancer specialists. One panel for your case.

Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.

Dr. Naresh Gundu
Medical Oncologist

Dr. Naresh Gundu

MBBS, DNB (Internal Medicine), DM (Medical Oncology)

View Profile
Dr. C. Raghavendra Reddy
Medical Oncologist

Dr. C. Raghavendra Reddy

MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)

View Profile
Dr. Bharati Devi Gorantla
Medical Oncologist

Dr. Bharati Devi Gorantla

MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)

View Profile
Dr. Owais Mohammed
Medical Oncologist

Dr. Owais Mohammed

MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)

View Profile
Dr. T. Raghavender Reddy
Medical Oncologist

Dr. T. Raghavender Reddy

MBBS, DM (Medical Oncology), MD (Radiation Oncology)

View Profile
Dr. N. Kiranmayee
Medical Oncologist

Dr. N. Kiranmayee

MBBS, DM (Medical Oncology), MD (Internal Medicine)

View Profile
Dr. Muralidhar Muddusetty
Surgical Oncologist

Dr. Muralidhar Muddusetty

MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)

View Profile
Dr. Raghavendra Naik
Surgical Oncologist

Dr. Raghavendra Naik

MBBS, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Mohammed  Imaduddin
Surgical Oncologist

Dr. Mohammed Imaduddin

M.B.B.S, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Vinay Mamidala
Surgical Oncologist

Dr. Vinay Mamidala

MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)

View Profile
Dr. Paila Gowri Naidu
Surgical Oncologist

Dr. Paila Gowri Naidu

MBBS, MS (General Surgery), M.Ch (Surgical Oncology), FMAS

View Profile
Dr. Venkata Sushma P
Radiation Oncologist

Dr. Venkata Sushma P

MBBS, MD (Radiation Oncology)

View Profile
Dr. Kirti Ranjan Mohanty
Radiation Oncologist

Dr. Kirti Ranjan Mohanty

MBBS, MD (Radiation Oncology)

View Profile
Dr. Gangadhar Vajrala
Radiation Oncologist

Dr. Gangadhar Vajrala

MBBS, MD (Radiation Oncology), MPH

View Profile
Dr. Basudev Pokhrel
Hematologist

Dr. Basudev Pokhrel

MBBS, M.D (Immunohematology & Blood Transfusion)

View Profile
Dr. Mohammed Imran
Interventional Radiologist

Dr. Mohammed Imran

View Profile
Dr. Vajja Sandeep Kumar
Surgical Oncologist

Dr. Vajja Sandeep Kumar

MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology

View Profile
Dr. Sridhar Kamani
Surgical Oncologist

Dr. Sridhar Kamani

MBBS, MS (General Surgery), DrNB (Surgical Oncology)

View Profile

Want a specific doctor for your case? Mention them when booking.

Book Free Consultation

You do not have to work this out alone

A 45-minute consultation with a specialist who treats this every week.

Book Free Consultation Call 1800 202 8726

Is hand-foot skin reaction on lenvatinib dangerous?

At mild grades, it is not dangerous — but it needs to be taken seriously from the start, because it can worsen quickly if friction and dryness are not reduced.

The reaction happens because lenvatinib interferes with signals that maintain skin repair, making the palms and soles more sensitive to everyday pressure. The skin does not fail all at once — it thickens, then cracks, then sometimes blisters.

Where it becomes medically significant is when blisters break or the skin becomes infected. NCCN guidance on targeted therapy toxicities recommends holding or reducing the lenvatinib dose for moderate to severe reactions — so telling your team promptly protects your treatment, not just your skin.

What actually helps once the reaction has started?

Thick moisturisers — particularly urea-based creams or petroleum jelly — are the most consistently recommended home treatment. Apply them generously and often.

Reduce everything that creates friction or heat on the affected skin: hot water, tight footwear, tools with hard grips, walking barefoot on hard floors.

If there are thickened patches, your team may apply a keratolytic treatment to soften them before they crack. This is straightforward and worth asking about early rather than waiting for a crack to appear.

Did you know?

Hand-foot skin reaction from targeted therapies like lenvatinib tends to concentrate at pressure points — the soles of the feet and the fingertips — rather than spreading evenly across the whole palm.

This means the same patch of skin absorbs friction every time you walk or grip something. Cushioning and reducing pressure matter as much as the cream itself.

Source: NCCN Guidelines for Management of Targeted Therapy-Related Toxicities

Explore 100 more Gastrointestinal & Liver Targeted Medicines topics

All Gastrointestinal & Liver Targeted Medicines →

Next step

Still not sure what applies to you?

Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.

Book Free Consultation Call 1800 202 8726
Common questions

Frequently asked questions

Will I definitely get hand-foot skin reaction on lenvatinib?

Not everyone does, but it is one of the more common side effects and it is worth starting preventive skin care whether or not you feel anything yet. Starting a thick moisturiser routine from the first week costs very little and is far easier than managing blistered skin once it has developed. If you are unsure which cream to use, ask your oncology nurse at your next appointment — they can recommend a formulation that is widely available in India.

Can I use any cream from the pharmacy, or does it need to be prescribed?

Many effective options are available without a prescription. Urea-based creams and petroleum jelly are both useful and widely available. What matters more than the brand is that the cream is thick rather than a light lotion, and that you apply it generously and consistently. Ask your team to confirm this is appropriate alongside anything else you are already using on your skin, particularly traditional oils or herbal preparations — some can increase sensitivity rather than reduce it.

Will this reaction mean my lenvatinib dose has to be reduced or stopped?

A mild reaction managed well at home usually does not require a dose change. A moderate to severe reaction — one that causes blistering, significant pain, or limits your daily activities — may need a temporary dose pause or reduction while the skin heals. NCCN guidance supports this approach, and for most people the dose can be restarted or adjusted rather than stopped permanently. Reporting the reaction early is what keeps the milder management options available to you.

My skin looks fine right now. Should I still start moisturising?

Yes. The most effective time to start is before any symptom appears, not after. The skin can change quickly once the reaction begins — sometimes within days. Starting a daily moisturising routine in your first week on lenvatinib, before anything is visible, is what the guidance recommends. Let your team know what product you are using, and ask them if there is anything they want you to avoid alongside it.

How long does the reaction last — will it get better over time?

The reaction does not always resolve completely while you remain on lenvatinib. For some people it stabilises with good skin care; for others it needs ongoing management throughout treatment. If the reaction settles to a mild level it becomes easier to live with. If it is moderate or severe and not improving, your team may adjust your dose — and the skin usually improves within a few weeks of a dose pause. Tell your team if it is not improving rather than assuming this is as good as it gets.

Call now Book free consultation